XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Details    
Sales, net $ 12,323 $ 10,964
Cost of goods sold 4,790 4,017
Gross profit 7,533 6,947
Operating expense    
Selling, general and administrative 2,888 2,929
Research & development 123 130
Total operating expenses 3,011 3,059
Operating income 4,522 3,888
Other income 8 10
Income before provision for income taxes 4,530 3,898
Provision for income taxes 996 874
Net income $ 3,534 $ 3,024
Earnings per common share (basic) $ 0.97 $ 0.83
Earnings per common share (diluted) $ 0.96 $ 0.83
Shares outstanding (basic) 3,655 3,644
Shares outstanding (diluted) 3,665 3,655
Other comprehensive income (loss)    
Foreign currency translation net of taxes of $0 in all periods $ (506) $ (54)
Total comprehensive income $ 3,028 $ 2,970